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1. Introduction 
Polyurethanes (PUs) are one of the most “pluripotent” synthetic polymer classes used in 
medical applications. Due to their structural versatility, they have been widely discussed as 
materials appropriate for biomedical applications (Abd El-Rehim & El-Amaouty, 2004; 
Guelcher et. al., 2007; Guelcher, 2008; Kavlock et. al, 2007; J.S. Lee et. al., 2001; Lelah & 
Cooper, 1987; Siepe et. al., 2007). Up to now, new PUs have been synthesized that possess 
good mechanical properties. Most of them are considered biocompatible on account of in 
vitro cytotoxicity evaluation.     
However, it is well known that structural and mechanical adaptability of PUs is not always 
accompanied by cell and tissue biocompatibility. Therefore, numerous data in the literature 
are focused on biocompatibilization or functionalization of PUs (Yao, 2008; Sartori, 2008, 
Huang & Xu, 2010). Some promising methods for the improvement of biological response of 
PUs are conjugation, blending or coating with natural polymers. Thus, polysaccharides as 
chitosan, cellulose and their derivatives (Raschip, 2009; Zia, 2009; Zuo, 2009), proteins and 
glycoproteins as collagen, fibrin, fibronectin (R. Chen et. al., 2010; Sartori et. al., 2008), 
proteoglycans and glycosaminoglycans (Gong et. al., 2010) and other molecules (Hwang & 
Meyerhoff, 2008; Hsu et. al., 2004; Makala et. al., 2006; Song et. al., 2005; Verma & Marsden, 
2005) are employed successfully for PUs modification. Owing its specific properties, 
hydroxypropylcellulose (HPC) is already used as binder, thickener, lubricating material 
(artificial tears) and emulsion stabilizer in pharmaceutical and food industry. Moreover, 
HPC may provide interactions through its hydroxyl radicals, being an excellent compound 
for copolymerization in scaffolds for tissue engineering and in drug delivery systems 
(Berthier et. al., 2011; D. Chen & Sun, 2000; Gutowska et. al., 2001; Raschip et. al., 2009; 
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Valenta & Auner, 2004). In previous studies we found that when added to PU structure, 
HPC improves hydrophilicity and mechanical properties of PUs by increasing the elasticity 
of the resulted materials (Macocinschi et. al., 2009).  
Considering the reviewed concept of biocompatibility as “the ability to exist in contact with 
tissues of the human body without causing an unacceptable degree of harm to the body” 
(Williams, 2008), our interdisciplinary work was focused on the synthesis of PU-based 
materials with improved ability to long-time functional integration. PU/HPC membranes 
were prepared by blending method. HPC was chosen due to its physical-chemical 
properties, its demonstrated biocompatibility and accessibility. The aim of the chapter is to 
highlight the most important criteria, able to predict the behaviour of material-tissue 
interfaces and the long-term material-tissue integration, in order to select most suitable 
compositions and morphologies for specific medical application. Thus, surface zeta (ζ) 
potential, wettability (as contact angle measurement and water uptake), pH modification 
after long time hydration and autoclaving, protein adsorption at protein physiological 
concentration and some relevant elements of bulk and surface morphology are treated as 
screening criteria for suitable membrane choice in the first part of the chapter. Biological 
performance evaluation, such as oxidative stress action, thrombogenicity and in vivo 
behaviour of PU/HPC membranes are further discussed.  
2. Materials and methods 
2.1. Preparation of polymer samples 
Preparation of PU/HPC samples was performed according to Fig. 1 as previously reported 
(Macocinschi et. al. 2009; Vlad et. al, 2010). 
 
Figure 1. Scheme of chemical structure and synthesis way of PUs/HPC  
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Briefly, isocyanate terminated urethane prepolymers were first synthesized by the 
polyaddition reactions between 4',4’-diphenylmethane diisocyanate (MDI) and macrodiols in 
N,N-dimethylformamide (DMF) as solvent. Poly(ethylene adipate)diol (PEGA, Mn = 2000 
g/mol), polytetrahydrofuran (PTHF, Mn = 2000 g/mol) or poly(propylene)glycol (PPG, Mn = 
2000 g/mol) were used as macrodiols. The urethane prepolymers were treated in a subsequent 
step with ethylene glycol (EG) as chain extender. Finally, HPC (average weight molecular 
weight Mw = 95 000 g/mol) was added to PU solutions to obtain the following compositions 
for all PU/HPC samples: macrodiol/MDI/EG/HPC = 52.24 /36.57/7.27/3.92 (weight ratios). As 
the molar ratio between isocyanate groups in MDI and the sum of hydroxylic groups in 
macrodiol and EG was 1.02, the excess of isocyanate groups linked to PU prepolymers were 
available to bind a part of HPC chains. Membranes with about 1 mm thickness were prepared 
by pouring PU/HPC DMF solutions in distilled water, at 40 oC. The formed films were then 
dried under vacuum for several days and kept in distilled water for solvent removing.  
To half of PUs with PEGA macrodiol in the soft segment no HPC was added to obtain PU-
PEGA reference sample. HPC containing samples based on PEGA, PTHF and PPG 
macrodiols were codified as PU-PEGA/HPC; PU-PTHF/HPC and PU-PPG/HPC, 
respectively. 
2.2. ζ potential determination 
ζ potential of the PU membranes was measured by streaming potential method using a 
commercial electrokinetic analyzer SurPASS, (Anton Paar GmbH, Graz, Austria). For each 
sample, ζ potential has been measured in 0.1 M NaCl solution at physiological 7.4 pH value, 
a 300 mbar electrolyte pressure and a 80 ml/min flow rate. For statistical reasons, four 
streaming potentials were measured. The mean value of these data was used for potential 
calculation by Fairbrother–Mastin equation, considering also the effect of surface 
conductivity (Luxbacher, 2006) 
2.3. Wettability 
Wettability of the PU membranes was determined by measuring the surface contact angle 
and water uptake. For surface contact angle, uniform drops of the tested liquid (double-
distilled water) with a volume of 2 μl were deposited on the film surface and the contact 
angles were measured after 30 s, using a video-based optical contact angle measuring device 
equipped with a Hamilton syringe in a temperature-controlled environmental chamber. All 
measurements were performed at room temperature of 25 C. Repeated measurements of a 
given contact angle were all within the range of ± 3 degrees. Water uptake was calculated as 
the ratio between fully hydrated and dried sample weights.   
2.4. Material extraction in a simulated biological microenvironment 
Material extraction in a simulated biological microenvironment was done for long period of 
time (over 2 months) in Hank’s Balanced Salt Solution (HBSS) without Ca2+ and Mg2+, with 
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glucose, and phenol red as pH indicator. For extraction experiments, 0.2 g of each 
membrane, cut in very small pieces (see Fig. 2), were incubated in 2 ml of HBSS solution at 
37oC. pH variation was monitored daily, based on phenol red indicator colour and 
measured after 1, 2, 3, 30 and 60 days of incubation using Mettler Toledo SevenGo SG2ELK 
pH-meter. 
2.5. Scanning Electron Microscopy (SEM) 
SEM analysis of PU/HPC membrane cross-sections was performed using a VEGA TESCAN 
microscope, in high vacuum mode, at an acceleration voltage of 30 kV.   
2.6. Protein adsorption 
Amount of protein adsorption on membrane surfaces was measured in three different 
conditions: (a) on individual protein solutions of fibrinogen (FB) at 3 mg/ml (95% clotable 
from Sigma-Aldrich) and serum albumin (SA) at 45 mg/ml (bovine SA (BSA) from Sigma-
Aldrich); (b) FB and BSA mixed solutions of physiological concentrations (3 mg/ml for BSA 
and 45 mg/ml for FB); (c) complex protein conditions (platelet poor blood plasma (PPP)). 
Prior adsorption experiment, the PU/HPC films were brought to equilibrium with 
phosphate buffer saline (PBS) up to reaching maximum hydration, for about 72 h. Briefly, 
PU/HPC hydrated membranes with 0.5 cm x 0.5 cm surface area were covered with 0.25 ml 
of one of the protein solutions or with blood plasma and kept at 37 oC for 30 min. FB and 
BSA concentration in incubated medium was determined before and after incubation. A 
turbidimetric method based on the formation of an insoluble complex with Na2SO4 was 
used for FB determination. The method based on antigen–antibody reaction was performed 
for SA measuring, using a Dialab kit, Austria. FB and SA reaction products were assessed on 
a Piccos 05 UV–VIS spectrophotometer at λ = 530 nm for FB and λ = 340 nm for SA. The 
adsorbed amount of proteins was calculated with the following relation: 
 2
( )
Adsorbedproetin(mg/cm )
Co Ce V
S
                   (1) 
where Co and Ce are the initial and post-incubation concentrations of protein solution 
(mg/ml), V is the incubated volume of the protein solution (ml) and S is the surface of the 
incubated  PU/HPC sample 
2.7. Total Antioxidant Status (TAS) 
TAS was measured in blood plasma obtained by human blood centrifugation at 1000 G for 
20 min. PU samples were incubated in blood plasma for 1, 2 and 3 days at 37 oC and mild 
orbital shacking. The TAS measurement was made by standard protocol provided by 
Randox TAS kit. Thus, 2,2’-azino-di-[3-ethylbenzthiazoline sulphonate] (ABTS)® was 
incubated with a peroxidase (metmyoglobine) and H2O2 to produce the ABTS®+ radical 
cations having a stable blue-green colour that was measured at 600 nm on a  
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spectrophotometer mentioned in the previous section. By adding blood plasma containing 
antioxidants a suppression of this colour to a degree which is proportional to their 
concentration is observed. Control serum (“standard” provided by the determination kit) 
was used for data validation. TAS values were calculated based on the measured 
absorbance in the standard, blood plasma sample and blank (buffer provided by the kit) 
before and after H2O2 adding. The absorbance differences (ΔA) between measurement 
before and after H2O2 adding for standard, sample or blank solutions were used for 
calculation of TAS concentration according to relations 2 and 3: 
 
concentrationof standard
Factor
A blank- Astandard
                         (2) 
 TASmMol/L=Factor ΔAblank-ΔAsample                 (3) 
2.8. Haemocompatibility testing 
Haemocompatibility of membrane surface was evaluated by haemolysis and coagulation 
tests. All tests were performed on well swollen PU samples in PBS. Haemolysis was 
determined using 0.25 ml of blood (human blood from healthy voluntary donors, collected 
on 3.8 % sodium citrate solution as anticoagulant in 9:1 v/v ratio) that was incubated with 1 
cm2 surface area PU samples for 30 min at 37 oC. Haemoglobin released from lysed 
erythrocytes was measured by spectrophotometric method at λ = 545. Prothrombin time was 
measured after 1 hour incubation of polymer sample in blood plasma. Standard laboratory 
method was applied using PT kit (Biodevice, Italy) and ACL 100 coagulometer. Blood 
plasma was obtained by blood centrifugation at 1000 G for 10 min. 
Platelet adhesion on material surface was determined based on number of platelet counted in 
0.1 ml platelet rich blood plasma (PRP), before and after membrane (0.5 cm x 0.5 cm) 
incubation for 1 hour at 37 oC. PRP was obtained by blood centrifugation at 400 G for 20 
min. Improved Neubauer haemocytometer was used for platelet counting. Clot weight test 
was performed by adding 0.2 ml of human blood upon well swollen samples with 1cm2 
surface area. The thrombus formation was started by adding 0.05 ml CaCl2 solution (0.025 
mol/l). Each formed thrombus was weighed and compared with control. Collagen film was 
used as positive pro-coagulant control and normal blood plasma without polymer sample as 
negative control. 
2.9. In vivo biocompatibility 
Subcutaneous implantation experiment was performed on Wistar 200 g weight male rats. 
Testing protocol was designed according to ISO 10993-2 (Animal Welfare Requirements) 
and the guidelines of Council for International Organizations of Medical Sciences (CIOMS). 
The pieces of autoclaved purified or unpurified membranes (0.5 x 0.5 cm size) were 
implanted under both sites (right and left) of dorso-lateral skin. Material purification was 
performed by immersion in sterile distilled water for 1 week and equilibration in 
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physiological salted sterile solution for 24 hours before subcutaneous implantation. All 
surgical procedures were done under thiopental anaesthesia, using a dosage of 35 mg/kg 
body weight. Lots of six animals for each material were taken in each experiment. The 
period of 10 or 30 days was chosen for material examination. Explanted samples together 
with surrounding tissue were fixed in 10% formaldehyde solution embedded in paraffin 
wax, sliced in 15 μm pieces and stained using Hematoxylin – Eosin (HE) method for cell 
examination and Masson’s trichrome for collagen fibres. 
3. Results and discussions 
3.1. Primary screening criteria for the appropriate selection of PU/HPC 
membranes for medical usage  
Biocompatibility of PUs, seen in terms of specific application, is a result of a “bio-
appropriate” expression of surface and bulk properties achieved by synthesis and scaffold 
fabrication methods. Thus, surface ζ potential and surface wettability are important 
characteristics responsible for specific tissue-material interaction mechanisms, starting with 
protein adsorption that can be influenced in turn by specific physiological/pathological 
tissue environment.  
3.1.1. Surface ζ potential and wettability 
Surface charge plays an important and active role in tissue-material interaction and must be 
considered in accordance with the targeted application. The importance of surface charge on 
cell adhesion, biofilm formation or thrombogenesis was demonstrated (Cai et. al., 2006; 
Colman & Schmaier, 1997; Kang et. al., 2006; Khorasani et. al., 2006). These phenomena are a 
consequence of adsorptive behavior of proteins on charged surface rather than the effect of 
electrostatic interactions with cells (Keselowsky et. al., 2003; Wilson et. al., 2005). Many data 
refer to the effect of surface charge on biological phenomena (Jelinek et. al., 2010; Kang et. 
al., 2006). However, there are not many data reporting surface charge and its clear relevance 
for biocompatibility of PU-based membranes. Moreover, it is difficult to estimate the electro-
kinetic properties of such surfaces, mainly due to the complexity of the chemical 
composition but also due to membrane variable porosity and swelling behavior that can 
influence surface charge values (Yaroshchuk & Luxbacher, 2010). ). Surface ζ potential of 
material is a property that reflects surface charge. Some reported data have shown that 
poly(ether-urethane)s exhibit a very negative (– 25 mV) ζ potential, while poly(ester-
urethane)s are less negative (- 12 mV). Contradictory data were published on the beneficial 
effect of positively (Khorasani et. al., 2006) or negatively charged surfaces (Sanders et. al., 
2005) on cells attachment and proliferation.  
Thus, this section is aimed to predict the influence of surface potential and wettability on the 
biocompatibility and biological performances of PU-based samples. Table 1 shows 
hydrophilic/hydrophobic properties and ζ potential of examined PU-based samples.  
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Material 
samples 
Contact angle
WU (%) ζ (mV) First immersion Second immersion 
θadv(o) θrec(o) H(%) θadv(o) θrec(o) H(%)
PU-PEGA 85.3±1.1 54.3±0.6 36.3 51.0±0.5 54.1±0.6 5.6 141±10 - 4.31 
PU-PEGA/HPC 84.8±1.1 44.2±0.5 47.9 52.6±0.5 43.7±0.5 16.9 140±4 + 3.14 
PU-PTHF/HPC 77.4±1.1 42.9±0.5 44.5 31.6±0.4 42.3±0.4 25.2 167±3 + 0.78 
PU-PPG/HPC 85.6±1.1 44.8±0.5 47.7 60.3±0.6 44.1±0.5 27.0 92±6 + 4.85 
Table 1. Dynamic contact angle values (θ) in contact with water, hysteresis (H) resulted from advanced 
(adv) and receded (rec) contact angles, water uptake (WU) (Macoconschi et. al., 2009) and ζ potential of 
the PU samples  
As one can see from Table 1, PU-PEGA has a slightly negative ζ potential, probably due to 
the presence of carboxylic groups resulted by the hydrolysis of residual isocyanate groups 
during membrane precipitation in water. After blending with HPC, the residual isocyanated 
groups linked to PU prepolymer are reacted with the hydroxyl groups of HPC and all 
PU/HPC membranes showed a slightly positive surface. The most hydrophilic sample (PU-
PTHF/HPC) exhibited the most neutral ζ potential. This observation is in accordance to 
other data that report dependence of surface charge on water swelling capacity (Aranberri-
Askargorta et. al., 2003).  
3.1.2. Extraction microenvironment 
The material biocompatibility can be appreciated through its effects on the physico-chemical 
properties of the physiological environment, especially on the pH. Thus, pH modification of 
HBSS buffer solutions after unsterilized and sterilized membranes incubation was 
measured. The results are shown in Figs 2 and 3 (1, PU-PEGA; 2- PU-PEGA/HPC; 3, PU-
PTHF/HPC; 4, PU-PPG/HPC). 
 
 
Figure 2. pH variation of HBSS buffer in which unsterilized membranes were incubated: A, PU-PEGA; 
B, PUs/HPC; C, pH variation curves 
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Figure 3. pH variation of HBSS buffer in which autoclaved PU/HPC membranes were incubated: A, 24 
h of incubation; B, 72 h of incubation; C, pH variation curves 
As one can see from Figs. 2 and 3, a long-period of incubation of unsterilized and sterilized 
(by autoclaving at 121 oC and 1 atm) PU/HPC membranes in simulated biological fluid did 
not meaningfully modify the physiological range pH value of the incubation environment, 
while a pronounced decrease of the environment pH was observed for pure PU-PEGA 
sample (Fig. 2 A). Thus, one can say that HPC gives an important contribution to hydrolytic 
stability of urethane and ester bonds of PU chains. 
For autoclaved samples, the variation of pH values of the environment for poly(ether-
urethane)s remains in the range of the physiological value, while PU-PEGA/HPC membrane 
induced a higher decrease of pH (Fig. 3), a normal result owing the higher thermal 
degradability of poly(ester-urethane)s (Guelcher, 2008). 
Another property that was changed by modifying PU membranes with HPC was the 
floatability (see Fig. 2B). As the surface wettability and water uptake for PU-PEGA sample is 
similar to HPC modified one (see Table 1), the reason of these different behavior could reside 
in different morphologies, as seen from SEM images of membrane cross-sections (Fig. 4).  
 
Figure 4. SEM image of PU-PEGA (A) and PU-PEGA/HPC (B) membrane cross-sections 
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PU-PEGA sample showed important bulk microporosity, with isolated pores, while PU-
PEGA/HPC presented smaller but interconnected pores allowing water diffusion and the 
decrease of the floatability. 
Thus one can conclude that PU/HPC membranes are slightly positively charged and they 
possess interconnected porous morphology influencing the wettability and floatability. They 
also showed a less pronounced influence on the biological media as compared to the pure 
PU membrane. 
3.2. Protein adsorption 
There are many data concerning mechanisms of protein adsorption on different surfaces 
(Gray, 2004; Scott & Elbert, 2007; Van Tassel, 2006; Wilson et. al., 2005). It was clearly 
demonstrated that proteins have amphoteric properties, being able to adsorb on both 
negatively and positively charged surfaces (Michelsen et. al., 2000; Van Tassel, 2006). The 
amount of adsorbed proteins is depending on their isoelectric points as well as on surface 
chemistry and hydrophilicity (Keselowsky et. al., 2003; Wertz & Santore, 2001). 
Hydrophobic surfaces manly interact with hydrophobic protein core that leads to the 
modification of the protein physiological conformation and its functionality. Opposite to 
hydrophobicity, superficial water maintains native protein conformation and specific 
functionality (Keselowsky et. al., 2003; Noinville & Revault, 2006). 
Many authors have reported protein adsorption behaviour on different surfaces using 
simulated solutions and highly sensible methods in which very low protein concentrations 
are detected. Thus, the adsorption of albumin solutions of different concentrations on pure 
silica or on silica modified with NH2 and CH3 terminated self-assembled monolayers 
(SAMs) (Noinville & Revault, 2006) and on silica-titanium surfaces (Kurrat et. al. 1997) was 
studied. Other authors reported the competitive adsorption of fibrinogen on mica (Gettens 
et. al., 2005; Tsapikouni & Missirlis, 2007). Surface adsorption of SA, FB, fibronectin (FN), 
immunoglobulins (IGs) and lysozyme were investigated to evaluate the surface 
biocompatibility (Bernsmann et. al., 2010; Pompe et. al., 2006; Rezwan et. al., 2005), each 
class of these proteins providing specific surface properties for targeted application. Thus, 
FN adsorption is relevant for the prediction of cell adhesion, lysozyme – for enzymatic 
degradability predisposition, IGs - for immune-specific interactions, while SA and FB 
adsorption have haemocompatibility predictive value. 
In order to estimate protein adsorption (retention) capacity of materials at blood or tissues 
contact, simulated physiological environment, close to normal blood conditions is required. 
For example, Bajpai, 2005 followed SA adsorption capacity of biomaterials at SA bulk 
concentration from 1 to 6 mg/ml, while Alves et. al., 2010 used mix protein conditions, 
considering physiological value for each protein. The mix protein adsorption conditions are 
considered to better reflect the complex interactions that occur between different proteins 
(Latour, 2008).    
PU/HPC membranes were previously demonstrated to possess good mechanical properties 
(elongation at break for dried/hydrated PU-PEGA/HPC = 71/84; for PU-PTHF/HPC = 72/159 
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and for PU-PPG/HPC = 53/55), appropriate for cardio-vascular applications (Macocinschi et. 
al., 2009). The physisorption of SA and FB is further highlighted as screening criteria for 
biocompatibility and, more specifically, haemocompatibility. Very short characteristics of 
SA and FB, important for protein-material interaction are given below. 
SA is a protein belonging to the so called “soft” class of proteins, with a molar mass of about 
65 kD for BSA and 67 kD for human SA (HSA). This protein represents about 60% of the 
blood proteins. Normal blood concentration of HSA is 35 – 50 mg/ml. This protein is 
involved in many physiological phenomena as carrier protein for fatty acids, metals, 
cholesterol, bile pigment, hormones and drugs. SA is also characterised by antioxidant 
properties (Bourdon et. al. 1999; Kouoh et. al., 1999; H. Lee et. al., 2000) that is higher in 
alkaline pH, up to 8 (H. Lee et. al., 2000). SA is preponderantly negatively charged, its 
isoelectric point being close to 4.8 (Carter & Ho 1994; Noinville & Revault, 2006). 
Approximately 67% of the secondary SA structure is represented by the α-helix. It was 
demonstrated that the stability of SA secondary structure strictly depends on pH (Freeman, 
2006) that influence the protein conformation. Thus, at pH = 5, SA takes almost spherical, 
native, unfolded shape that forms a thick layer on the adsorptive surfaces. At pH = 7 (close 
to physiological pH), due to molecular spreading, SA forms an extended contact area with 
adsorptive surfaces. This behavior can be influenced by surface charge, surface functionality 
and functionality distribution, surface morphology or wettability conditions (Wilson et. al., 
2005). The role of adsorbed SA on biomaterial biocompatibility is still ambiguously 
described in the literature. While some authors have demonstrated biocompatibility 
improvement of material with increased adsorption of SA (Eberhart et.al. 1987; Marconi et. 
al., 1996; Randrasana et. al., 1994), others demonstrated a better biocompatibility of SA-
resistant surfaces (Ostuni et. al., 2001; Wan et. al., 2006).  
FB is a high molecular weight (340 kD) complex glycoprotein that has 2 molecular 
domains, each of them consisting of three polypeptide chains called Aα, Bβ and γ. 
Molecular updated analysis of FB can be found in recent reports (Cardinali et.al, 2010). FB 
is an important factor of haemostasis. Through fibrin network formation as first cell 
scaffold, FB is involved in wound healing and tissue regeneration. Its normal blood 
concentration varies from 2 to 4 mg/ml. In inflammations or in other pathological statuses 
- as cardiovascular diseases -  FB can reach up to 7 mg/ml, therefore adsorption properties 
of biomaterials for this protein should be carefully analysed, especially for those targeted 
for blood contact applications.  
The results obtained in adsorption experiments of SA and FB from both individual and 
mixed solutions on PU/HPC membranes are presented in Fig. 5. 
No significant differences between adsorption behavior of both proteins in their pure and 
mixed solutions were registered, except a small tendency to decrease adsorbed BSA from 
mixed solution as compared to individual solution, especially on PU-PEGA and PU-
PEGA/HPC membranes, where FB, with a higher molecular weight, showed a higher 
affinity. 
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Figure 5. Amount of adsorbed BSA (left) and FB (right) from individual protein solutions and in co-
adsorptive environment (mixed protein solution) of physiological concentrations, i.e., 3 mg/ml for FB 
and 45 mg/ml for BSA 
Figure 6 shows the ratios of adsorbed BSA and FB from mixed protein solutions and from 
blood plasma. In both studied conditions and for all membranes, the amount of adsorbed 
SA is higher than that of adsorbed FB, a normal result considering the lower concentration 
of FB in solutions. The total amount of the adsorbed SA and FB proteins from blood plasma 
is lower as compared to that adsorbed from mixed solutions due to the competitive 
adsorption of some other blood plasma proteins. Moreover, the ratio between adsorbed FB 
and SA is lower in blood plasma than in mixed solutions.  
 
 
 
Figure 6. Total amount of adsorbed FB and BSA from: A – mixed protein solution at 3 mg/ml FB and 45 
mg/ml BS physiological concentration; B - human blood plasma with 2.98 mg/ml initial FB 
concentration and 45.3 mg/ml initial SA concentration 
As conclusion, comparing PU-PEGA and PU-PEGA/HPC membranes one can observe that 
small amount of polysaccharide rich in functional substituents can bio-stabilize PU 
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structures and improve their resistance for autoclaving procedures as important step in 
ready to use biomaterials preparation. From all the data presented in this section, one can 
say that the more hydrophilic PU-PTHF/HPC membrane could be the most appropriate for 
biomedical applications.  
3.3. In vitro and in vivo performances of PU/HPC membranes 
The biocompatibility of PUs are widely discussed and questioned, mostly in the past. In the 
last two decades new generation of PUs that combine mechanical advantages with the 
biological performances emerged (Gisselfa et. al., 2002; Jordan & Chaikof et. al., 2007; Jun et. 
al., 2005; Kavlock et. al., 2007; Parveen et. al., 2008). For many years it has been considered 
that PUs biocompatibility is spotless due to their products of degradation, e.g., aromatic 
polyamines. As it is well known for the most part of biocompatible materials, the life time of 
their in vitro functionality is quite short. This is a consequence of their intrinsic physico-
chemical properties, on one hand, and of the tissue action on the material, on the other hand 
(Anderson, 2001; Guelcher, 2008; Shen & Horbett, 2001).  
3.3.1. Oxidative in vitro behavior  
Oxidative degradation of PUs caused by hydrolytic or enzymatic mechanism was 
intensively discussed (Christenson et. al., 2004; Guelcher, 2008; Gary & Howard, 2002; 
Sutherland et. al., 1993). First of all, PUs designed for tissue-contact devices undergo 
hydrolytic degradation as a result of watering with physiological solutions. This process has 
an impact especially on poly(ester-urethane)s that can generate hydroxy-acids, being 
susceptible to induce reactive oxygen species (ROS) production following the material-
tissues interaction. By means of this mechanism, PUs can be implied in the sustained 
oxidative degradation and a wide range of pathological states.  
As it is well known, ROS can trigger subtle mechanisms responsible for diseases generation 
through the peroxidation of cell membrane lipids and DNA damage (Marnett, 2002; Tribble 
et. al., 1987; Yagi, 1987). The most susceptible organs to oxidative aggression are the heart, 
vessels, lung, gut, liver, brain and nerves (Ames et. al., 1993; Förstermann, 2008; Paradis et. 
al., 1997; Rahman et. al., 2002; Sayre et. al., 1997).  
In a normal body state, ROS appear constantly as a result of some biological errors or as a 
consequence of some short living reactive intermediate products generated by the cell 
aerobic metabolism. Endogenous enzymatic and nonenzymatic pathways are responsible 
for the formation of free radicals. These pathways are balanced by two endogenous 
antioxidant pathways, which form the TAS (see fig. 7).  
While some harmful material characteristics can be marked as cytotoxic or proinflammatory 
by standard testing, others, such as oxidative stress (that causes long-time material failure), 
are undetectable by using short period testing. Thus, well known biocompatible materials 
were found to display surface alteration or cracking after long-time implantation. Adding 
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antioxidant compounds to materials can improve their resistance against tissue degradation 
(Oral et. al., 2006; Stachelek et. al., 2006; Wattamwar et. al., 2010). 
 
Figure 7. Schematic representation of the oxidative/antioxidative balance with enzymatic and 
nonenzymatic tissue pathways 
Antioxidant defensive systems are present in both cells and extracellular environment. SA 
molecules are the most important antioxidants in blood. Due to their high concentration and 
polyvalent possibilities to fit with oxygen free radicals, SA molecules are considered to be 
the main plasmatic components of defence that assure neutralisation of more than 70% of 
ROS (Bourdon & Blache, 2001).  
Assigning to SA molecules the main role in protective effect, we analysed the interaction of 
PU/HPC membranes with blood plasma, following the plasma antioxidant status. To define 
the importance of SA adsorption on material surface, the membranes were incubated at 37 
oC in blood plasma and TAS was measured periodically. The results are shown in Fig. 8. 
Two PU samples (PU-PEGA and the more hydrophobic PU-PPG/HPC) had significant 
tendency to quickly decrease TAS activity in the first 48 hours. Due to the complexity of 
TAS, it is difficult to speculate on the mechanism by which the decreasing phenomenon 
arises and certainly more examinations are needed. However, one can suppose that PU-
PEGA alter the TAS activity as a result of plasma pH modification that leads to sustained 
free radical generation in the presence of the material. The mechanisms by which TAS 
activity is lowered after PU-PPG/HPC incubation could not be related directly to SA 
antioxidant activity, but to some other oxidant pathways that need further investigations.    
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Figure 8. TAS evolution after PU/HPC incubation in blood plasma at 37 oC 
3.3.2. In vitro haemocompatibility 
Haemocompatibility involves compatibility with blood cells and blood plasma in other 
words, nonhaemolytic and nonthrombogenic behavior. Haemolysis is a mechanism by 
which erythrocytes (red blood cells) are destroyed through cell membrane lyses. Erythrocyte 
membrane lyses may occur as a result of environment pH modification or by cytotoxic 
action on erythrocyte membrane. Thus, both lipid (by lipid peroxidation) and protein (by 
protein modification) compounds can be affected. 
Thrombogenesis is a complex phenomenon by which thrombus is formed by blood clotting. 
As a physiological event, haemostasis implies the activation of the enzymatic cascades in 
which three main factors are involved – vascular, cellular and plasmatic (Edmunds, 1998).   
A synthetic material can induce haemostasis activation by surface charge, hydrophobicity 
and/or released products of degradation. It is widely recognised that both positively and 
negatively charged as well as hydrophobic surfaces can induce thrombus formation. This 
can be explained by involvement of several mechanisms as presented in Fig. 9.  
A positive charge can be favourable for FB adsorption, followed by its conformational 
modification and adhesion of platelets and leukocytes (monocytes). Adherent cells are 
activated and they release numerous molecules that lead finally to FB cleavage with fibrin 
network formation (clot). Among platelet secreted factors are platelet thromboplastin, fibrin 
stabilizing factor, serotonin, anti-heparin factor, and others. Adherent (activated) monocyte 
releases thrombogen tissue factor (TF). Mechanism triggered by positive and hydrophobic 
surfaces is mainly related to extrinsic coagulation pathway (B. Furie & B. C. Furie, 2008).  
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A negative charge acts as an activator of plasmatic factor XII (Hageman factor) that involves 
contact system and intrinsic coagulation pathway (Zhuo et.al. 2006). This mechanism also 
involves high molecular weight and positively charged kininogen (HMW) and plasma 
thromboplastin (factor XI). Contact mechanism is tightly related to inflammatory events 
because some intrinsic pathways factors are direct activators of neutrophils. Whole 
mechanism of contact blood coagulation is still unclear. Some authors hypothesized that it 
can also be induced by adsorbed FB (Colman & Schmaier, 1997) and hydrophobic surfaces 
(Zhuo et. al., 2006). As for intrinsic coagulation mechanism of thrombus formation, this can 
also be activated by negatively charged low density lipoproteins (LDL), the molecules that 
adhere to the vessel walls in some pathologic conditions associated with cardiovascular 
risks (Krieter et. al., 2005). This possible mechanism should be taken into account because 
almost all pathological situations in which blood-assisted devices are used are accompanied 
by high level of cardiovascular risk factors (high level of LDL, cholesterol, triglycerides and 
modified blood pressure). 
 
Figure 9. Contact coagulation and extrinsic (tissue factor) coagulation blood pathways 
PUs are promising materials for implantable and non-implantable blood-interacting devices. 
They combine an increased elasticity with good mechanical resistance. For 
haemocompatibility evaluation of PU/HPC materials discussed above, the haemolytic and 
thrombotic potentials were determined by standard and adapted methods (see section 2). 
The obtained results are summarised in Table 2.   
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All studied membranes showed a low haemolytic activity, lower for PU/HPC than for pure 
PU-PEGA sample.  
 
Material 
samples 
Haemolytic 
potential 
Thrombotic potential 
Released Hb 
(%)1 
FB (mg/ml)2 PT (s)3 
Adhered platelet 
(cells x 105/mm2)
%  blood 
clot amount4 
PU-PEGA 6,7±0,2 2,79±0,04 11,06±0,4 1,40±0,08 40% 
PU-PEGA/HPC 5,2±0,1 2,87±0,04 10,9±0,09 0,82±0,05 29% 
PU-PTHF/HPC 4,2±0,2 2,90±0,01 10,9±0,09 0,86±0,05 15% 
PU-PPG/HPC 5,5±0,1 2,77±0,07 10,9±0,07 1,25±0,09 89% 
Table 2. Haemolytic and thrombotic potential of the PU/HPC samples: Hb-haemoglobin; FB-
fibrinogen; PT- prothrombin time 
As for thrombotic action, a correlation between adsorbed FB, platelet adhesion and amount 
of formed clot was registered, while no significant variation was recorded for PT. This latter 
parameter was kept within the normal limits (see footnote 3).  
The judgement strictly based on the haemocompatibility results permits to state that all 
examined materials have an acceptable thrombotic potential (referring to physiological 
requirements). Considering clot amount and all the other characteristics discussed above, it is 
obvious that PU-PEGA and PU-PPG/HPC are not suitable for long-time functional integration. 
3.3.3. In vivo biocompatibility and performance 
The technological progress achieved in the last decades in apparently unrelated areas 
(biomaterials, biotechnology, cell and molecular biology, tissue engineering, and polymer 
science) has generated a boost in the development and use of devices for medical and/or other 
type of applications (e.g. artificial organs, biosensors, catheters, heart valves) (Shastri, 2003). In 
spite of real improvement of this sort of devices there are still some important problems to face 
since implanted medical devices usually reveal different degree of loss of functionality over 
time after insertion (Göpferich, 1996). Tissue or blood-device interface interactions or a lack of 
biocompatibility resulting from the normal homeostatic response of the body to the 
implantation injury, determining an inadequate in vivo functionality and longevity, remains a 
serious concern (Callahan & Natale, 2008; Fujimoto et. al., 2007; Morais et. al., 2010). 
In order to protect the body from the foreign object, under normal physiological conditions, 
the body reacts by several nonspecific mechanisms (immune and inflammatory cells 
recruitment), usually termed foreign body reaction (FBR) (Anderson, 2001). There is an 
imperative call for knowing the degree to which the pathophysiological conditions are 
                                                                 
1 Percentage of released Hb over negative control 
2 FB concentration remained in blood plasma after incubation. FB control was 2,98 ± 0,04 mg/ml  
3 Physiological normal value according to related laboratory are between 8,3 s and 11,3 s    
4 Percentage of blood clotting over negative control (blood without incubated material)   
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created, the homeostatic mechanisms are disturbed, and the resolution of the inflammatory 
response (simple put, the measure of the host reaction). All of these will finally establish the 
effective compatibility of a specific device. In the same time, understanding these reactions 
(the implant versus the host and the host versus the implanted device) will reduce health 
problems to the beneficiary of the device and device malfunction. Usually, for practical 
reasons, the homeostatic mechanisms are separately assessed even if it is well known that 
they are profoundly interrelated (Sieminski & Gooch, 2000). 
The first event after a device/material insertion is that the body generates quickly a sort of 
“interface” via nonspecific adsorption of plasma/tissue soluble proteins on the implant 
surface (Shen & Horbett, 2001). There are some well identified elements that determine the 
FBR strength: device material composition, surface chemistry, size and shape, porosity, 
degradation, velocity as well as the place of device insertion (Ratner & Bryant, 2004)  
As presented shortly below, tissue injury associated with device implantation, initiates a 
complex set of events (nonspecific inflammatory reaction and wound healing responses) 
that will bring about a FBR (Wahl et. al., 1989). The stages of inflammatory responses are 
well studied and can be separate in acute and chronic inflammatory periods. 
The initial phase, acute stage, starts quickly in matter of hours, lasts for several days (up to 
14 days) and is underlined by rapid device interface generation and typical for this phase, 
different degree of neutrophil leucocytes responses (Jiang et. al., 2007). The main result of 
this stage is the building of temporary interface material-tissue, the cleaning-up of the injury 
place and the vasodilation that bring more blood in the affected area. 
The acute inflammatory reaction typically decline in maximum 14 days with a 
“biocompatible” material. Some local conditions (extent of surgical injury, body reactivity) 
or properties of the implanted device can trigger a chronic inflammatory evolution 
(Kirkpatrick et al., 1998). 
Numerous blood and tissue proteins such as cytokines (e.g. tumor necrosis factor (TNF), 
interleukins (IL-6, IL-8), matrix metalloproteases (MMP-1, MMP-3), granulocyte-
macrophage growth factors (GM-CSF)) are released, and leukocytes adhere to the 
endothelium of the blood vessels and infiltrate the injury site. These proteins are strong 
calling factors for monocytes, cells which will migrate to the site of inflammation where they 
will differentiate into macrophage. If inflammatory stimuli persist, the conditions that can 
lead to chronic inflammation are created. Cell population of this stage of inflammatory 
reaction is usually characterized by the presence of monocytes, macrophages, and 
lymphocytes (Bhardwaj et al., 2010). Also, in this step it can be noticed that the proliferation 
of blood vessels (angiogenesis), and connective tissue occurs that participate in remodelling 
of the affected area. The formation of blood vessels is crucial for wound healing, supplying 
necessary factors for tissues reconstruction. In the end, the granulomatous tissue is replaced 
by an extracellular matrix (ECM) that acts not only as a physical scaffold but also as an 
essential modulator of the biological processes, including differentiation, development, 
regeneration, repair, as well as tumour progression. The end phase of the FBR draws in 
wrapping the implant by a collagenic fibrous capsule that limits the implant and therefore 
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prevents it from interacting with the surrounding tissue. The main tissue events of the 
material-tissue interaction and wound healing are schematically presented in Fig. 10. 
Morphologic aspects (light microscopy) of the acute tissue reaction to subcutaneous 
implanted polyurethane (PU-PTHF/HPC) at 10 days of implantation and chronic 
inflammation at 30 days of implantation are shown in Fig. 11. The study was conducted on 
Wistar male rats using the protocol described in section 2. 
 
 
Figure 10. Fibrosis and fibrous encapsulation. End stage healing response to biomaterials. GF – growth 
factor (PD – platelet derived, T – transforming, bF – basic fibroblastic); IL – interleukin; PGL – 
prostaglandin. 
 
Figure 11. Light microscopy images of tissue response to implantation of subcutaneous non-washed 
PU-PTHF/HPC (PU): A - A2, 10 days of implantation; B -B2, 30 days of implantation. All images – HE 
staining. Objective magnifications are indicated in the left bottom corner 
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Unwashed (unpurified) material was implanted first, to highlight the importance of the 
properly prepared biomaterial for medical usage. From Fig. 11, A-A2 images, it can be easily 
seen as an intense acute inflammation reaction with numerous neutrophil 
polymorphonucleate leucocytes (PMN), edema and early fibrin network formation away 
from implantation site. These results suggest that an inappropriately prepared material at 
some stage in manufacture and/or manipulation can delay wound healing. As we expected, 
at 30 days of implantation (Fig.11, B-B2 images), inflammatory chronic reaction was really 
strong for related material, with the characters of neovascularised granulomatous tissue 
(VNGT) and giant cells (GC). 
In the end of this chapter, comparative study concerning long-time potential functionality 
based on evolution of chronic inflammation of PUs/HPC discussed above was done. The 
histological images of 30 days implanted, properly purified PUs/HPC are shown in Fig. 12. 
There were found chronic inflammations with VNGT and FBR with GC for PU-PEGA/HPC 
(A-A2 images) and PU-PPG/HPC samples (C-C2 images). Moreover, granuloma formation 
(G) as result of macrophage material degradation was present at material-tissue interface of 
PU-PPG/HPC (C and C1 images in Fig. 12). 
 
Figure 12. Light microscopy images of tissue response following 30 days subcutaneous implantation of 
washed PUs/HPC. A–A2, PU-PEGA/HPC; B-B2, PU-PTHF/HPC and C-C2, PU-PPG/HPC. B2, Masson’s 
trchrome staining; all other images - HE staining. Objective magnifications are indicated in left bottom 
corner 
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The absence of GC and rich granulomatous tissue ingrowth through large material pores 
was observed for PU-PTHF/HPC sample (Fig.12, B-B2 images). Morphological aspect for 
PU-PTHF/HPC implant suggests a material-tissue integration and regenerative remodelling. 
Moreover, the fibroblast-rich tissue ingrowth only from one side of the membrane highlights 
the bifacial behavior of the implanted sample, with potentially tubular or cavity-like device 
performances. Thus, considering PU-PTHF/HPC increased haemocompatibility, oxidative 
and other biocompatibility advantages discussed above, we presume a cardiovascular-
device performance for this PU sample.  
4. Conclusions and further perspectives   
Polyester and polyether urethane structures with improved bulk and surface characteristics 
by blending with small amount of biocompatible cellulose derivative, HPC, are screened for 
long-time functional integration. The stability of the pH value of biological media and the 
ratio of adsorbed albumin and fibrinogen from blood plasma were found to be the most 
valuable screening criteria to evaluate the blood-interface functionality, but not only. These 
criteria could provide information on material capacity to keep stability of the main body 
balances (oxidant/antioxidant, haemostasis/haemolysis) that are responsible for material 
acceptance in the early phase, followed by structural and functional integration in the later 
stages. These characteristics together with other important material properties as surface 
neutral charge and desired porous structure are keys points for good results expectance as 
was demonstrated. Another PU characteristic highlighted in our study was washability for 
potentially proinflammatory compounds removal. Due to interconnected mechanisms of 
thrombosis and inflammation, even haemocompatible PU, but with chronic prolonged 
inflammatory capacity (through itself or some released compound) will certainly get to fail 
its haemocompatibility in vivo. From this point of view we demonstrate an acceptable 
stability of some PU membrane by autoclaving and long-time watering in biological buffers. 
Further studies are necessary on extended classes of polyurethanes in the aim to prepare 
and keep ready to use pre-equilibrated and safe PUs for medical applications.      
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